bromodeoxyuridine has been researched along with Cerebrovascular Moyamoya Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, M; Fukai, N; Matsushima, Y; Yamamoto, K; Yamamoto, M | 1 |
| Aoyagi, M; Fukai, N; Matsushima, Y; Sakamoto, H; Shinkai, T; Yamamoto, K; Yamamoto, M | 1 |
2 other study(ies) available for bromodeoxyuridine and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease.
Topics: Anticoagulants; Becaplermin; Bromodeoxyuridine; Cell Movement; Cells, Cultured; Culture Media, Conditioned; DNA; Humans; Mitogens; Moyamoya Disease; Muscle, Smooth, Vascular; Nitric Oxide; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Recombinant Proteins | 1998 |
Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease.
Topics: Adolescent; Arteries; Bromodeoxyuridine; Cell Division; Cells, Cultured; Child; DNA; Epidermal Growth Factor; Female; Growth Substances; Humans; Infant; Insulin-Like Growth Factor I; Kinetics; Male; Moyamoya Disease; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor | 1991 |